|
1
|
Hallgren J and Pejler G: Biology of mast
cell tryptase: an inflammatory mediator. FEBS J. 25:234–241.
2006.
|
|
2
|
Schwartz LB, Yunginger JW, Miller J,
Bokhari R and Dull D: Time course of appearance and disappearance
of human mast cell tryptase in the circulation after anaphylaxis. J
Clin Invest. 83:1551–1555. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Metz M, Grimbaldeston MA, Nakae S,
Piliponsky AM, Tsai M and Galli SJ: Mast cells in the promotion and
limitation of chronic inflammation. Immunol Rev. 17:304–328. 2007.
View Article : Google Scholar
|
|
4
|
Ackermann MR: Acute inflammation.
Pathologic Basis of Veterinary Disease. McGavin MD and Zachary JF:
Mosby Elsevier; Philadelphia: pp. 117–118. 2007
|
|
5
|
Ackermann MR: Chronic inflammation and
wound healing. Pathologic Basis of Veterinary Disease. McGavin MD
and Zachary JF: Mosby Elsevier; Philadelphia: pp. 1742007
|
|
6
|
Kovanen PT: Mast cells: multipotent local
effector cells in atherothrombosis. Immunol Rev. 217:105–122. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Theoharides TC and Conti P: Mast cells:
the Jekyll and Hyde of tumor growth. Trends Immunol. 25:235–241.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zizzo N, Patruno R, Zito FA, Di Summa A,
Tinelli A, Troilo S, Misino A, Ruggieri E, Goffredo V, Gadaleta CD
and Ranieri G: Vascular endothelial growth factor concentrations
from platelets correlate with tumor angiogenesis and grading in a
spontaneous canine non-Hodgkin lymphoma model. Leuk Lymphoma.
51:291–296. 2010. View Article : Google Scholar
|
|
9
|
Ribatti D and Vacca A: Overview of
angiogenesis during tumor growth. Angiogenesis: An Integrative
Approach from Science to Medicine. Figg WD and Folkman J:
Springer-Verlag; Berlin: pp. 161–168. 2008, View Article : Google Scholar
|
|
10
|
Nielsen HJ, Hanse U, Christensen IJ,
Reimert CM, Brunner N and Moesgaard F: Independent prognostic value
of eosinophil and mast cell infiltration in colorectal cancer
tissue. J Pathol. 189:487–495. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bowrey PF, King J, Magarey C, Schwartz P,
Marr P, Bolton E and Morris DL: Histamine, mast cells and tumour
cell proliferation in breast cancer: does preoperative cimetidine
administration have an effect? Br J Cancer. 82:167–170. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Erol YA and Ozdemir O: Mast cells: Are
they really related to invasiveness of endometrial carcinoma?
Pathol Res Pract. 206:426–428. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Graham RM and Graham JB: Mast cells and
cancer of the cervix. Surg Gynecol Obstet. 123:3–9. 1996.
|
|
14
|
Tan ST, Wallis RA, He Y and Davis PF: Mast
cells and hemangioma. Plast Reconstr Surg. 113:999–1011. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ribatti D, Vacca A, Nico B, Quondamatteo
F, Ria R, Minischetti M, Marzullo A, Herken R, Roncali L and
Dammacco F: Bone marrow angiogenesis and mast cell density increase
simultaneously with progression of human multiple myeloma. Br J
Cancer. 79:451–455. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Blair RJ, Meng H, Marchese MJ, Ren S,
Schwartz LB, Tonnesen MG and Gruber BL: Tryptase is a novel, potent
angiogenic factor. J Clin Invest. 99:2691–2700. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ribatti D, Ranieri G, Nico B, Benagiano V
and Crivellato E: Tryptase and chymase are angiogenic in vivo in
the chorioallantoic membrane assay. Int J Dev Biol. 55:99–102.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ruoss SJ, Hartmann T and Caughey GH: Mast
cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest.
88:493–499. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hartmann T, Ruoss SJ, Raymond WW, Seuwen K
and Caughey GH: Human tryptase as a potent, cell-specific mitogen:
role of signaling pathways in synergistic responses. Am J Physiol.
262:528–534. 1992.PubMed/NCBI
|
|
20
|
Abe M, Kurosawa M, Ishikawa O, Miyachi Y
and Kido H: Mast cell tryptase stimulates both human dermal
fibroblast proliferation and type I collagen production. Clin Exp
Allergy. 28:1509–1517. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Frungieri MB, Albrecht M, Raemsch R and
Mayerhofer A: The action of the mast cell product tryptase on
cyclooxygenase-2 (COX2) and subsequent fibroblast proliferation
involves activation of the extracellular signal-regulated kinase
isoforms 1 and 2 (erk1/2). Cell Signal. 17:525–533. 2005.
View Article : Google Scholar
|
|
22
|
Briggaman RA, Schechter NM, Fräki JE and
Lazarus GS: Degradation of the epidermal-dermal junction by
proteolytic enzymes from human skin and human polymorphonuclear
leukocytes. J Exp Med. 160:1027–1042. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kaminska R, Helisalmi P, Harvima RJ,
Naukkarinen A, Horsmanheimo M and Harvima IT: Focal
dermal-epidermal separation and fibronectin cleavage in basement
membrane by human mast cell tryptase. J Invest Dermatol.
113:567–573. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huttunen M and Harvima IT: Mast cell
tryptase and chymase in chronic leg ulcers: chymase is potentially
destructive to epithelium and is controlled by protease inhibitors.
Br J Dermatol. 152:1149–1160. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lohi J, Harvima I and Keski-Oja J:
Pericellular substrates of human mast cell tryptase: 72 000 dalton
gelatinase and fibronectin. J Cell Biochem. 50:337–349. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Saarinen J, Kalkkinen N, Welgus HG and
Kovanen PT: Activation of human interstitial procollagenase through
direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J
Biol Chem. 269:18134–18140. 1994.PubMed/NCBI
|
|
27
|
Gruber BL, Marchese MJ, Suzuki K, Schwartz
LB, Okada Y, Nagase H and Ramamurthy NS: Synovial procollagenase
activation by human mast cell tryptase: dependence upon matrix
metalloproteinase 3 activation. J Clin Invest. 84:1657–1662. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Stack MS and Johnson DA: Human mast cell
tryptase activates single-chain urinary-type plasminogen activator
(pro-urokinase). J Biol Chem. 269:9416–9419. 1994.PubMed/NCBI
|
|
29
|
Kemik O, Sumer A, Kemik SA, Purisa S and
Tuzun S: Circulating levels of VEGF family and their receptors in
hepatocellular carcinoma. Bratisl Lek Listy. 111:485–488.
2010.PubMed/NCBI
|
|
30
|
Shimanuki Y, Takahashi K, Cui R, Hori S,
Takahashi F, Miyamoto H and Fukurchi Y: Role of serum vascular
endothelial growth factor in the prediction of angiogenesis and
prognosis for non-small cell lung cancer. Lung. 183:29–42. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Carvalho RF, Nilsson G and Harvima IT:
Increased mast cell expression of PAR-2 in skin inflammatory
diseases and release of IL-8 upon PAR-2 activation. Exp Dermatol.
19:117–122. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ribatti D, Nico B, Vacca A, Marzullo A,
Calvi N, Roncali L and Dammacco F: Do mast cells help to induce
angiogenesis in B-cell non-Hodgkin’s lymphomas? Br J Cancer.
77:1900–1906. 1998.PubMed/NCBI
|
|
33
|
Ribatti D, Polimeno G, Vacca A, Marzullo
A, Crivellato E, Nico B, Lucarelli G and Dammacco F: Correlation of
bone marrow angiogenesis and mast cells with tryptase activity in
myelodysplastic syndromes. Leukemia. 16:1680–1684. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ribatti D, Molica S, Vacca A, Nico B,
Crivellato E, Roccaro AM and Dammacco F: Tryptase-positive mast
cells correlate positively with bone marrow angiogenesis in B-cell
chronic lymphocytic leukemia. Leukemia. 17:1428–1430. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Molica S, Vacca A, Crivellato E, Cuneo A
and Ribatti D: Tryptase-positive mast cells predict clinical
outcome of patients with early B-cell chronic lymphocytic leukemia.
Eur J Haematol. 71:137–139. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ranieri G, Ammendola M, Patruno R, Celano
G, Zito FA, Montemurro S, Rella A, Di Lecce V, Gadaleta CD,
Battista De Sarro G and Ribatti D: Tryptase-positive mast cells
correlate with angiogenesis in early breast cancer patients. Int J
Oncol. 35:115–120. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ribatti D, Finato N, Crivellato E,
Marzullo A, Mangieri D, Nico B, Vacca A and Beltrami CA:
Neovascularization and mast cells with tryptase activity increase
simultaneously with pathologic progression in human endometrial
cancer. Am J Obstet Gynecol. 193:1961–1965. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Benítez-Bribiesca L, Wong A, Utrera D and
Castellanos E: The role of mast cell tryptase in neoangiogenesis of
premalignant and malignant lesions of the uterine cervix. J
Histochem Cytochem. 49:1061–1062. 2001.PubMed/NCBI
|
|
39
|
Cervello M, Foderàa D, Florena AM, Soresi
M, Tripodo C, D’Alessandro N and Montalto G: Correlation between
expression of cyclooxygenase-2 and the presence of inflammatory
cells in human primary hepatocellular carcinoma: possible role in
tumor promotion and angiogenesis. World J Gastroenterol.
11:4638–4644. 2005.
|
|
40
|
Ranieri G, Gadaleta-Caldarola G, Goffredo
V, Patruno R, Mangia A, Rizzo A, Sciorsci RL and Gadaleta CD:
Sorafenib (BAY 43-9006) in hepatocellular carcinoma patients: from
discovery to clinical development. Curr Med Chem. 19:938–944. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Llovet JM, Di Bisceglie AM, Bruix J,
Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M,
Talwalkar J and Gores GJ: Panel of Experts in HCC-Design Clinical
Trials: Design and endpoints of clinical trials in hepatocellular
carcinoma. J Natl Cancer Inst. 100:698–711. 2008. View Article : Google Scholar
|
